Cite

HARVARD Citation

    Jerusalem, G. et al. (2015). A new era of improving progression-free survival with dual blockade in postmenopausal HR+, HER2− advanced breast cancer. Cancer treatment reviews. 41 (2), pp. 94-104. [Online]. 
  
Back to record